SMi reports:Metys Pharmaceuticals, Ensysce Biosciences & AstraZeneca will be speaking and presenting at the 19thAnnual Pain Therapeutics conference in London, this May. Pain Therapeutics 2019 will cover the leading advances in pain therapeutics, exploring late […]
Puma Biotechnology, a biopharmaceutical company, has expanded two additional cohorts from the Phase II SUMMIT clinical trial investigating its lead drug candidate neratinib in patients with solid tumors who have an activating EGFR or HER2 […]
Celltrion has entered into a partnership with iProgen Biotech, a pre-clinical stage Canadian biotechnology company, for the development of a series of antibody-drug conjugates against HER21 and CD20 and other validated antibody targets. Under the […]
The US National Institutes of Health (NIH) has announced it has enrolled patients into the first Phase I trial of an innovative, experimental universal vaccine candidate H1ssF_3928. The study will be conducted at the NIH […]
SMi reports: In four weeks’ time, Injectable Drug Delivery 2019 will gather an international audience to include regulatory, device design, packaging and formulation professionals. SMi’s 2ndannual Injectable Drug Delivery Conference will take place at the […]